Log In
Print
BCIQ
Print
Print this Print this
 

clonidine topical gel, clonidine (formerly ARC-4558)

  Manage Alerts
Collapse Summary General Information
Company Arcion Therapeutics Inc.
DescriptionTopical 0.1% gel formulation of clonidine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetic neuropathy
Indication DetailsTreat painful diabetic neuropathy
Regulatory Designation U.S. - Fast Track (Treat painful diabetic neuropathy)
Partner BioDelivery Sciences International Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today